Metastatic Breast Cancer — SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer
Citation(s)
A Belgian Multicenter Phase II Randomized Trial in her2 Negative Metastatic Breast Cancer Evaluating Consolidation Antiangiogenic Therapy With SU11248 After Response to Taxane Chemotherapy Induction